Caspase-3 Deficient MEFs with Mutant Caspase-3 Re-Introduced


Mouse embryonic fibroblast (MEF) line deficient in caspase-3 that are reconstituted with constitutively expressed mutant versions of the protease.

Key Benefits

  • An immortalized caspase-3-deficient MEF cell line.
  • Tool to study protease induced apoptosis.

Technical Summary

Emory inventors have discriminated a previously unknown role of the prodomain region of caspase-3. By reintroducing specific caspase mutations into an immortalized MEF cell line deficient in caspase-3 activity, investigators found a genomic region that rendered these cells more susceptible to death signals. Furthermore, through creating point mutations within the prodomain region of caspase-3, the investigators found amino acid D9 to be vital for the proper function of the enzyme.

Image: Generation of stable cell lines expressing mutant Caspase-3

Generation of stable cell lines expressing mutant Caspase-3

Developmental Stage

  • Stable cell line C3−/−C3∆28, which lacks the prodomain but retains the catalytically active C163 site created.
  • Stable cell line C3−/−C3∆28C163A, which lacks the prodomain and contains the mutation C163A, rendering it catalytically inactive created.

Publication: Ponder, K.G., Boise, L.H. (2019). Cell Death Discovery 5(1), 56.

Patent Information

Tech ID: 20088
Published: 11/20/2020